These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 8885499)

  • 1. Gemcitabine for lung cancer.
    Drug Ther Bull; 1996 Sep; 34(9):71-2. PubMed ID: 8885499
    [No Abstract]   [Full Text] [Related]  

  • 2. Gemcitabine--a major advance?
    Thomas A; Steward WP
    Ann Oncol; 1998 Dec; 9(12):1265-7. PubMed ID: 9932153
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary on "Gemcitabine: single-agent and combination therapy in non-small cell lung cancer". The Oncologist 1999;4:241-251.
    Edelman MJ
    Oncologist; 1999; 4(3):252-5. PubMed ID: 10394592
    [No Abstract]   [Full Text] [Related]  

  • 4. The emerging role of gemcitabine in lung cancer: part I.
    Bunn PA
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-1. PubMed ID: 9194472
    [No Abstract]   [Full Text] [Related]  

  • 5. Veno-occlusive disease of the liver induced by gemcitabine.
    Dobbie M; Hofer S; Oberholzer M; Herrmann R
    Ann Oncol; 1998 Jun; 9(6):681. PubMed ID: 9681086
    [No Abstract]   [Full Text] [Related]  

  • 6. An unusual case of gemcitabine-induced radiation recall.
    Squire S; Chan M; Feller E; Mega A; Gold R
    Am J Clin Oncol; 2006 Dec; 29(6):636. PubMed ID: 17149004
    [No Abstract]   [Full Text] [Related]  

  • 7. Gemcitabine hydrochloride: combination of activity and tolerability. Proceedings of a symposium. Jerusalem, Israel, November 14, 1993.
    Anticancer Drugs; 1995 Dec; 6 Suppl 6():5-65. PubMed ID: 8718418
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of single-agent gemcitabine in advanced non-small cell lung cancer: a review.
    Hansen HH; Sørensen JB
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-38-S7-41. PubMed ID: 9194478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic-uremic syndrome caused by gemcitabine.
    Nackaerts K; Daenen M; Vansteenkiste J; Vandevelde A; Van Bleyenbergh P; Demedts M
    Ann Oncol; 1998 Dec; 9(12):1355. PubMed ID: 9932169
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) given as a twice weekly schedule to previously untreated patients with non-small cell lung cancer.
    Lund B; Ryberg M; Petersen PM; Anderson H; Thatcher N; Dombernowsky P
    Ann Oncol; 1994 Nov; 5(9):852-3. PubMed ID: 7848889
    [No Abstract]   [Full Text] [Related]  

  • 11. Gemcitabine in non-small cell lung cancer.
    Sørensen JB
    Lung Cancer; 1995 Apr; 12 Suppl 1():S173-5. PubMed ID: 7551926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy for advanced non-small cell lung cancer (NSCLC).
    Manegold C
    Lung Cancer; 2002 Dec; 38 Suppl 3():S47-50. PubMed ID: 12468145
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical, toxicological and pharmacological aspects of gemcitabine.
    Guchelaar HJ; Richel DJ; van Knapen A
    Cancer Treat Rev; 1996 Jan; 22(1):15-31. PubMed ID: 8625330
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of gemcitabine in cancer therapy.
    Toschi L; Finocchiaro G; Bartolini S; Gioia V; Cappuzzo F
    Future Oncol; 2005 Feb; 1(1):7-17. PubMed ID: 16555971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [First-line non-small-cell lung cancer: role of gemcitabine].
    Barata F
    Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S20-2. PubMed ID: 16273006
    [No Abstract]   [Full Text] [Related]  

  • 16. Purtscher retinopathy and necrotizing vasculitis with gemcitabine therapy.
    Banach MJ; Williams GA
    Arch Ophthalmol; 2000 May; 118(5):726-7. PubMed ID: 10815173
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
    Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
    Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Severe interstitial pneumonitis related to Gemcitabine].
    Sabria-Trias J; Bonnaud F; Sioniac M
    Rev Mal Respir; 2002 Oct; 19(5 Pt 1):645-7. PubMed ID: 12473953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-agent gemcitabine in non-small cell lung cancer: the French experience.
    Le Chevalier T; Gottfried M
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-47-S7-49. PubMed ID: 9194480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maculopapular rashes secondary to gemcitabine injection for non-small-cell lung cancer.
    Chen YM; Liu JM; Tsai CM; Whang-Peng J; Perng RP
    J Clin Oncol; 1996 May; 14(5):1743-4. PubMed ID: 8622097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.